The DNA nanotechnology market is booming, driven by precision medicine and AI integration. Over 1,500 research projects and 300 clinical trials highl ...

Precision BioSciences, Inc. (Nasdaq: DTIL), a clinical stage gene editing company utilizing its novel proprietary ARCUS® platform to develop in vivo g ...

For years, breast cancer treatment has been guided by genetic alterations found in tumor tissue, typically through invasive biopsies.

Third Federal, a $17bn bank based in Cleveland, selected DNA as they sought to improve operations and efficiency, offer the best possible products for consumers and homeowners, deploy new products ...